Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct;38(5):780-787.
doi: 10.5114/ada.2020.95383. Epub 2020 May 26.

Evaluation of the relationship of IL-17A and IL-17F gene polymorphisms with the response to treatment in psoriatic patients using biological drugs: a case-control study in patients in Eastern Turkey

Hatice Uce Ozkol  1 , Gokhan Gorgisen  2 , Can Ates  3 , Halil Özkol  2 , Yasin Tülüce  2 , Hulya Savas  4 , İsmail Musab Gulacar  2
Affiliations

Evaluation of the relationship of IL-17A and IL-17F gene polymorphisms with the response to treatment in psoriatic patients using biological drugs: a case-control study in patients in Eastern Turkey

Hatice Uce Ozkol et al. Postepy Dermatol Alergol. 2021 Oct.

Abstract

Introduction: IL-17A and IL-17F cytokines have important roles in the pathogenesis of psoriasis.

Aim: To examine the associations of IL-17A rs2275913 and IL-17F rs763780 variants with the development of psoriasis and whether these polymorphisms affect the responsiveness of biological agents.

Material and methods: In our case-controlled study, which included 83 psoriatic patients who were treated with different biological agents and 69 healthy controls, we genotyped IL-17A rs2275913 and IL-17F rs763780 variants using TaqMan probes.

Results: We did not observe statistically significant changes in genotype frequencies of IL-17A rs2275913 (p = 0.922) and IL-17F rs763780 (p = 0.621) variants between patient and control groups. Although we did not find any association between these polymorphisms and the development of psoriasis, statistical analyses showed that individuals with the IL-17A AA genotype had shorter disease duration (9.09 ±6.82, p = 0.020) and AA genotype frequency was higher in patients who used single conventional treatment (34.6%; p = 0.025). IL17A/rs2275913 variant in terms of disease duration, it was observed that individuals with AA genotype had a shorter disease duration (less than 10 years) (p = 0.009). For patients with PASI90 and PASI100 response, the IL-17A AA genotype was significantly higher (p = 0.015). On the other hand, we did not detect any statistically significant correlation between variants and response to biological agents.

Conclusions: According to our results, we may suggest that rs2275913 variant seems to be associated with disease duration, use of single conventional treatment and responsiveness of PASI90 and PASI100 however both variants have no effect on the susceptibility to psoriasis in the population of Eastern Turkey.

Keywords: IL-17A; IL-17F; adalimumab; psoriasis; secukinumab; ustekinumab.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

Cited by

References

    1. Dand N, Mahil SK, Capon F, et al. Psoriasis and genetics. Acta Derm Venereol. 2020;30:55–64. - PMC - PubMed
    1. Oskay T, Kundakci N. Genetic findings in psoriasıs. T Klin J Dermatol. 2000;10:139–45.
    1. Capon F. The genetic basis of psoriasis. Int J Mol Sci. 2017;18E2526 - PMC - PubMed
    1. Stylianaki EA, Karpouzis A, Tripsianis G, Veletza S. Assessment of gap junction protein beta-2 rs3751385 gene polymorphism in psoriasis vulgaris. J Clin Med Res. 2019;11:642–50. - PMC - PubMed
    1. Pușcaș AD, Cătană A, Pușcaș C, et al. Psoriasis: association of interleukin-17 gene polymorphisms with severity and response to treatment. Exp Ther Med. 2019;18:875–80. - PMC - PubMed